Skip to main content
Clinical Trials/NCT05641532
NCT05641532
Completed
Not Applicable

Physical Activity Intervention for Persons Newly Diagnosed With Multiple Sclerosis

University of Alabama at Birmingham1 site in 1 country16 target enrollmentJanuary 17, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis (MS)
Sponsor
University of Alabama at Birmingham
Enrollment
16
Locations
1
Primary Endpoint
Feasibility metric: Process
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This single group pre-post pilot intervention will examine the feasibility and initial effect of a 12-week behavioral intervention, based on the Behavior Change Wheel and Capability-Opportunity-Motivation-Behavior (COM-B) model and remotely delivered through electronic newsletters and online one-on-one video conferencing, for promoting physical activity and secondarily reducing fatigue and quality of life in persons newly diagnosed with MS (diagnosed with MS within the past 2 years). The investigators hypothesize the proposed 12-week intervention will be feasible based on process, resource, management, and scientific outcomes. The investigators further hypothesize that individuals who receive the 12-week intervention will demonstrate an increase in physical activity behavior, particularly daily step counts, and reduce fatigue.

Registry
clinicaltrials.gov
Start Date
January 17, 2023
End Date
August 8, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Elizabeth Barstow

Faculty Advisor

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • ≥ 18 years old
  • Diagnosed with multiple sclerosis for 2 or fewer years
  • Fully ambulatory
  • No relapse within the last 30 days
  • Non-active (Godin Leisure-Time Exercise Questionnaire - Health Contribution Score \< 14)
  • Able to read 14-point font size
  • Internet \& video conferencing access
  • Undergoing disease-modifying therapy

Exclusion Criteria

  • Pregnancy
  • Moderate or high risk for undertaking physical activity (≥ 2 affirmatives on the Physical Activity Readiness Questionnaire)

Outcomes

Primary Outcomes

Feasibility metric: Process

Time Frame: 12 weeks

Process assesses participant recruitment, retention, and adherence i. Recruitment and refusal rates ii. Retention, attrition, and adherence rates to study procedures

Feasibility metric: Management

Time Frame: 12 weeks

Management assesses data management.

Feasibility metric: Overall safety

Time Frame: 12 weeks

Overall safety will be assessed through the number of adverse events.

Feasibility metric: Resource

Time Frame: 12 weeks

We will assess the resources required for the study.

Change of Physical Activity levels through the Abbreviated International Physical Activity Questionnaire from baseline and 12 weeks

Time Frame: 12 weeks

Physical activity will be assessed using the Abbreviated International Physical Activity Questionnaire. Participants will complete this questionnaire at baseline and 12 weeks.

Change of Physical Activity levels through Accelerometry from baseline and 12 weeks

Time Frame: 12 weeks

Physical activity will be assessed using an ActiGraph accelerometer. Participants will wear an accelerometer on a belt around their waist during the waking hours of a 7 day period. Participants will complete this at baseline and 12 weeks

Change of Physical Activity levels through the Godin Leisure-Time Exercise Questionnaire from baseline and 12 weeks

Time Frame: 12 weeks

Physical activity will be assessed using the Godin Leisure-Time Exercise Questionnaire. Participants will complete this questionnaire at baseline and 12 weeks.

Secondary Outcomes

  • Changes of self-report measures of quality of life through the Multiple Sclerosis Impact Scale-29 at baseline and 12 weeks(12 weeks)
  • Change of self-report measures of Fatigue through the Fatigue Severity Scale from baseline and 12 weeks(12 weeks)
  • Formative evaluation(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials